Search the Community

Hello, I’m currently a hobbyist grower and ER nurse. I have been researching extensively on the medical benefits of cannabis. I sincerely believe it will slow or stop the growth of many different cancers. I’m upset that it isn’t encouraged more by doctors or offered by doctors. I want to help. I can help you make RSO or make it for you, help you choose and grow plants, give you grow advice, grow for you. My assistance is free for cancer patients. I live south of Kalamazoo outside of the city. Yes it’s free. I want to help. I’m not rich but I will do whatever I can. Please contact poster via private message private email or other outside links not allowed in open forum . if you want to see some of what I do.

Read on to see the consensus from research spanning 50 years from USA, UK, Canada, Australia, and everywhere else. Just under 300 studies along with independent and government reports were collected, yet the research keeps pointing to the same thing. People driving after using cannabis drive a little bit slower. States with Legalized and Medical Marijuana have fewer fatal car accidents. My guess is that the fewer fatal accidents are due to substituting alcohol and other medications for cannabis. Marijuana makes drivers drive slower. That's about it. Don't believe me, take the official government word directly from NIDA: NHTSA 2017 Marijuana-Impaired Driving A Report to Congress The National Highway Traffic Safety Administration did its own tests in 2015 and found that THC showed no increased crash risk. Crash Fatality Rates After Recreational Marijuana Legalization in Washington and Colorado. CANNABIS USE AND DRIVING: Evidence Review Canadian Drug Policy Coalition (CDPC) Simon Fraser University NHTSA The Incidence and Role of Drugs in Fatally Injured Drivers 1992 NHTSA Marijuana and Actual Driving Performance 1993 CRASH CHARACTERISTICS AND INJURIES OF VICTIMS IMPAIRED BY ALCOHOL VERSUS ILLICIT DRUGS University of Michigan Study 1997 CANNABIS: OUR POSITION FOR A CANADIAN PUBLIC POLICY REPORT OF THE SENATE SPECIAL COMMITTEE ON ILLEGAL DRUGS 2002 Psychomotor Performance, Subjective and Physiological Effects and Whole Blood D9 -Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption Marinol Patient Information Marinol Patient Information See the full studies here: https://komornlaw.com/35-years-research-reports-driving-cannabis-marijuana/ Grab all of the studies here, 200mb http://komornlaw.com/wp-content/uploads/2018/03/marijuana-driving-research.zip

The information below has been transcribed from the "Cannalytics Recommendation for Edible Makers" PDF, which can be downloaded here. It is important to note that the times and temperatures listed below were obtained using purified THCA and that the optimal times and temperatures may be different depending upon your application. If you are having troubles with the efficiency/repeatability of your process, a couple of things to consider might be using an oven thermometer to ensure that your oven's temperature setting is properly calibrated as well as pre-heating any cookware that will be used to decarboxylate material. If you are interested in quantifying the potency levels of your edibles, please contact a cannabis analysis lab in your area. ==================================================================== Introduction Edibles can be a wonderful method for cannabis patients to ingest their medicine without the harmful side effects of smoking. However, since the material will not be heated by the patient prior to ingestion, it is important that edible makers ensure that their products have been fully decarboxylated for maximum therapeutic activity. What is decarboxylation?
 In living cannabis plants, the cannabinoids are synthesized in an acidic form. This form has little effect on humans and must be heated to lose a carbon dioxide molecule to become active. What are the optimal conditions for decarboxylation? Maximum conversion of THCA into THC has been reported to occur by heating for 15 minutes, at 300 degrees Fahrenheit, which results in a 70% conversion rate. Insufficient heating will result in the majority of the cannabinoids to remain in their acidic form, while excessive heating will result in degradation of THC to CBN or vaporization of the compounds. Cannalytics recommends heating plant material in the oven prior to mixing it with any other ingredients. Batching and Dosages In order for your test results to have maximum relevance, Cannalytics recommends that edibles be made in as large of batches as possible and that each dosage be of the same weight. This will reduce variability in the potency reported for each product allowing patients to better predict how a product will make them feel. The preferred method for reporting the cannabinoid concentration of edibles is by total milligrams of each cannabinoid present. This is obtained by multiplying the mass of each edible by its concentration (% w/w). Patients may be surprised to see that the average cannabinoid content of edibles is between 30-90 mg, thinking that this is too little an amount to have an effect. Here’s an example to demonstrate that this is an appropriate amount. Let’s assume that an average joint as a mass of 1000 mg (1g) with a THC concentration of 15%, meaning there are 150 mg of THC in this joint. Now consider the fact that 70% of THC is destroyed by combustion, meaning that only 45 mg of THC would remain to reach the patient’s lungs. From this example it is easy to see that edibles within the 30-90 mg range would indeed be at a therapeutic concentration. The Advantage of HPLC Because our high-pressure liquid chromatography method does not involve heating the samples for quantification, we are uniquely positioned to distinguish between products that have been properly decarboxylated prior to analysis from those that have not. The chromatograms below are examples of edibles that we have received to date. You can see the extent of decarboxylation by comparing the relative areas of the THC and THCA peaks. References Dussy et. al. (2005). Isolation of d9-THCA-A from hemp and analytical aspects concerning the determination of d9-THC in cannabis products. Forensic Science International; 149: 3-10.

New Device Tests Marijuana Using an App As the American marijuana culture becomes more mainstream, the modern-day stoner becomes increasingly more conscientious about the quality and overall safety of the weed he or she purchases. Recent reports of marijuana being contaminated with mold, E. Coli and other wicked toxins has caused concern within the cannabis community; and the piece of mind that comes with stringent testing has become invaluable to the consumer. Unfortunately, without government regulations to help guide the marijuana industry, there is an abundance of the weed purchased across the United States that is untested. However, an innovative new company has launched a product aimed at eliminating the risk of smoking dope laced with questionable materials like fecal matter, or even worse. MyDx is a handheld marijuana-testing device that allows cannabis users the flexibility of examining the purity of their pot before smoking it… better yet, before paying for it. This high technology, which was developed by the California-based CDx Life, operates by communicating with a downloadable smartphone app that detects potency levels and other pertinent information. For about $399, stoners can stroll into a dispensary, pop a small nugget into the device, and walk out feeling confident that they were not just railroaded by some fly-by-night operation slinging ditch weed. “When presented with a sample of cannabis, MyDx will deliver a strain analysis revealing the abundance of medically-relevant cannabinoids such as THC and CBD, whose ratios have been shown to play a key role in how a specific strain makes people feel,” according to the company’s website. The Canna sensor is also being programmed to look for terpenoids, which give each strain of cannabis its unique smell, and in synergy with the other compounds found in weed, further contribute to the overall medical effect of the plant. MyDx co-founder Daniel Yazbeck says his product will do away with the marijuana consumer being forced into making purchases based on blind faith. "What people are inhaling today is more or less a black box,” he said. “MyDx is a device that will improve consumer's health and empower an industry with the science it deserves to achieve true and practical quality control.” http://www.hightimes.com/read/new-device-tests-marijuana-using-app

Mad Science Marijuana: Lab Develops Odorless Weed A legion of mad marijuana breeders operating at a high-security laboratory in Vancouver recently began manipulating the DNA of hundreds of strains in hopes of developing a new generation of wicked weed for the sick. According to reports, MediJean is currently experimenting with about 224 marijuana strains in an attempt to breed a selection of high-potency varieties to be used by patients suffering from a broad range of debilitating ailments, including cancer,multiple sclerosis and epilepsy. Jean Chiasson, Chief Executive Officer for MediJean, says that his scientists have already produced about 40 new strains that possess a great ability to heal and help, and one strain, he boasts, is completely odorless. Chiasson says the work that takes place at MediJean is unlike that of traditional medical grow operations; these scientists are an elite group of researchers that work to alter the chemical footprint of existing marijuana breeds and balance them with other ingredients to produce strains with very different effects. What’s interesting is that while this fortress of the high sciences is busy producing super strains for the sick, they are doing so under a security clearance just one step beneath the requirements of a military base. That’s because recent regulations imposed by Health Canada make it mandatory for all marijuana facilities to have super security. In the case of MediJean, the facility’s location is kept confidential; surveillance cameras are positioned all over the property; photography is strictly prohibited and visitors are required to go through checkpoints upon entering or leaving the facility. While we are on the edge of our seats to test this company’s odorless weed – add a vape pen to that we you have ganja you can smoke anywhere. Trix

Drug Maker Secures Patent on THC and CBD as Cancer Treatment A pharmaceutical company in the United Kingdom, specializing in the research and development of pot-based drugs, recently obtained early approval on a patent covering two specific cannabinoids found in marijuana to be used as treatment for brain cancer. According to a press release, GW Pharmaceuticals will hold the patent rights to the two primary compounds found in marijuana, THC and CBD, for use as medicine for patients suffering from gliomas -- the most common form of malignant brain tumor. The United States Patent Office informed the drug company earlier last week, by way of Notice of Allowance, that a patent application filed several years ago was officially deemed a genuine invention and is now in its final stages of approval. GW Pharmaceuticals must now submit the appropriate fees before final approval for their cancer combatant patent is granted. Try saying that five time fast. “The subject patent specifically covers a method for treating glioma in a human using a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) wherein the cannabinoids are in a ratio of from 1:1 to 1:20 (THC:CBD) with the intent to reduce cell viability, inhibit cell growth or reduce tumor volume,” according to a statement issued by the company. GW’s patent application was originally filed in 2009, which detailed the company’s invention of the “use of a combination of cannabinoids in the manufacture of a medicament for use in the treatment of cancer.” Yet, it is believed the verbiage was revised at some point, noting more specific information, including THC and CBD ratios and the fact that the treatment is used against brain cancer. Justin Gover, GW’s Executive Chief Officer, says that the company recently initiated its first wave of clinical trails to study glioma, a disease that accounts for nearly 50% of new brain cancer diagnoses in the United States each year. “The treatment of glioma is part of our exciting new orphan drug program which includes a number of therapeutic targets and demonstrates the flexibility of GW’s proprietary cannabinoid platform in treating a broad range of disease types.”

Marijuana Breathalyzer Close to Reality "If You Are Going to Get High, You Better Not Drive," or some other public service slogan will surely be plastered on billboards all across America as soon as science figures out a way to stick it to the average citizen with the marijuana breathalyzer. Ever since legalized recreational marijuana was made a reality last year by voters in Colorado and Washington, the powers that be have been brainstorming new ways in which to prosecute the legal marijuana user. Obviously, driving stoned is high on the list of no-nos. In fact, a team of researchers recently published a document in the medical journal Clinical Chemistry that suggests a breath test -- similar to the testing procedures for alcohol intoxication -- may be the best way for law enforcement to analyze a motorist’s THC level. Researchers believe that the breath method of testing could eventually phase out the controversial THC-blood test currently being used to prosecute people in courtrooms all over the country. Researchers say that in a study group consisting of everyday stoners and weekend warrior-style occasional smokers, they were able to detect levels of THC, the principle psychoactive cannabinoid in marijuana that would be most likely to affect the way a person drives, by collecting breath samples. What they found was that while every breath sample collected tested positive for THC almost immediately following the participant getting high, the only group to maintain a positive test after four hours were the everyday stoners. Interestingly, while 90% of the part-time smokers tested positive for THC within an hour of smoking, none of them tested positive after about 90 minutes. This means that a marijuana breathalyzer manufactured under these principles would only be effective for somewhere between 30 minutes to two hours immediately following a person’s participation in an old-fashioned toke and choke ritual. So far, the outcome of the study holds some good news for the occasional smoker, but how would a law enforcement device that measures THC levels affect the die-hard smoker chiefing it up on the regular? In its current form, the advent of the marijuana breathalyzer could prove extremely bad for the regular cannabis connoisseur because those people have the potential to test positive for THC after a week of abstinence -- sometimes longer depending on the body fat of the individual. Technically, the user could be more to stone-sober than stoned and still be arrested for driving under the influence. Without a doubt, more research is needed in order to properly determine marijuana intoxication levels in this manner. “Breath may offer an alternative matrix for testing for recent driving under the influence of cannabis, but is limited to a short detection window,” researchers concluded in their study titled “Cannabinoids in Exhaled Breath following Controlled Administration of Smoked Cannabis.

video I ran Across today while perusing Y/T. Has a nice subject matter and well formed content.

Medical Marijuana Patient Fired For Failing Drug Test May Have Found Loophole to Keep Job Jul 11, 2012 Sonny Meyers is a former DISH Network employee from Colorado. He was fired earlier this year for failing a drug test after using medical marijuana to help deal with the symptoms of ocular migraines, which can be debilitating. The 69 year old was hired by DISH Network 5 years ago to fill various roles with the company including sales and equipment verification., which is similar to a fraud investigation unit. Meyers received a doctor’s recommendation to use medical marijuana to treat his migraines in 2010. The medicine greatly relieved his symptoms and he continued to use it. According to Meyers, he checked the company’s employee handbook before starting to use the drug, and he saw nothing which prohibited employees from being registered medical marijuana patients or using medial marijuana. Meyers felt especially protected because medical marijuana is legal in Colorado and he is a registered user. Meyers added that he never used medical marijuana on the job. In May 2011, Meyers was given a random drug test and tested positive for THC. The company fired Meyers, citing that they follow federal law, not state law. His claim for unemployment was denied, and his argument to the Industrial Claims Appeals Office was denied, as he was found to be the cause of is dismissal. Meyers did not give up there. He filed an additional complaint with the Colorado Court of Appeals, and the jury noted that because medical marijuana use was not forbidden in DISH Network’s employee drug policy guide, he had no way to know that medical marijuana was not allowed. So far, a final ruling has not been made regarding Meyers’ case. But the outcome has the potential to have large repercussions for businesses in Colorado and other medical marijuana states. This case could set the precedent for how companies handle drug testing and firing when it comes to legal medical marijuana patients. Meyers hopes that by speaking out about the situation and having it told by the media that he will be able to shed light on the unfair treatment of medical marijuana patients throughout the country. http://news.nuggetry...le-to-keep-job/ Trix

More Research Is Needed Before Medical Marijuana DUI Laws Are Proposed And Passed All 50 states have laws that say driving while impaired by alcohol or drugs is a crime punishable by law. However, these laws become hazy when it comes to the use of medical marijuana and driving. Over the past couple of years, around 14 states have set laws for this issue, coming up with a threshold for deciding when a driver is too high to be driving. The decision was made that if a driver is caught with more than 5 nanograms of THC per milliliter of blood, they are technically intoxicated and too high to be driving. Just like a regular DUI, the driver would then receive a fine, lose their license temporarily, face increased insurance fees, and possible jail time. This can all cause a driver fees up to $10,000. Some of these states are even adopting a zero tolerance law for driving under the influence of marijuana, which would result in an automatic conviction. The problem with these laws is how exactly the medical marijuana smoker decides when he or she is too intoxicated? How would you know when smoking, if you have consumed enough marijuana to have more than 5 nanograms of THC per millimeter of blood in your system? The answer is not as simple as waiting one hour to drive, after every drink you consume. All drivers know the guidelines for drinking alcohol and driving. But for marijuana, the guidelines remain hazy. Through toxicology, marijuana is detectable in tests of blood, hair, urine and saliva. But how quickly does the THC pass through one’s system? In smokers who don’t smoke regularly, the THC may remain in their system for several hours. However patients who smoke every day, the THC remains in their system for days. This means a heavy marijuana smoker may not smoke for days and be fully alert at the wheel, but will still have very high levels of THC in their blood. Tests have been conducted on drunk drivers versus drivers who are high, and the results are incredibly different. Whereas a drunk driver displays incredibly aggressive behavior behind the wheel, a driver who is high on marijuana has heightened awareness, and therefore tends to drive more cautiously. All of this information points clearly to the fact that more research needs to be conducted before DUI medical marijuana laws are proposed and passed. As it stands now, these laws are discriminatory against medical marijuana users. http://bigbudsmag.com/lifestyle/legal/article/more-research-needed-medical-marijuana-dui-laws-are-proposed-and-passed-july Trix

13 Things You May Not Know About Cannabis By Laurel Dewey 1. Smoking marijuana is actually the least effective way to benefit from the medicinal power of marijuana. Opt for liquid extracts, cannabis butters or medicated oils to truly gain the deepest use from this healing plant. 2. The term “marijuana” is actually a Mexican slang term that the U.S. government bestowed on the cannabis plant in the 1930’s. The true name of the plant is simply: cannabis. 3. In all of recorded history, nobody has ever died from consuming or smoking marijuana. 4. The two main medicinal species are Cannabis Sativa and Cannabis Indica. Sativas affect the mind more and are more exhilarating while the Indicas work more on the body, providing physical relief and relaxation. 5. The term cannabinoids refers to the multiple compounds found within the marijuana plant. Cannabis has over sixty known cannabinoids, many of which have not been thoroughly studied. What people may not realize is that we were all born with cannabinoid receptors in our brains, liver, stomach and nerve tissue, making us human sponges to soak up the benefits of cannabis. 6. Marijuana liquid extracts were routinely given to babies in the late 1800’s and early 1900’s to effectively combat teething pain. 7. There are single strains of marijuana that can help you sleep, reduce pain, relieve muscle spasms and calm the mind. In other words, one marijuana strain can take the place of four different drugs, eliminating the multiple side effects of the pharmaceuticals. 8. Queen Victoria regularly depended upon cannabis indica extracts to ease her menstrual cramps. 9. Most people have heard about THC, the main psychoactive constituent in marijuana. However, there is another very important element in the plant called CBD that is non-psychoactive. Breeders are creating high CBD marijuana strains that have less than 1% of THC, making them non-psychoactive. High CBD marijuana has been shown to be excellent for stress, anxiety, inflammation and reducing the spread of cancerous tumors. 10. A 1974 conducted at the University of Virginia discovered that the cannabinoids in cannabis shrunk cancerous tumors and killed cancer cells, leaving the healthy cells alone. 11. Contrary to the propaganda that “pot kills brain cells,” research has shown that marijuana can actually protect brain cells, even when those cells have damaged by chronic alcohol abuse. In addition, marijuana has been shown to slow the progression of Alzheimer’s Disease, Parkinson’s Disease and protect victims of epilepsy, strokes and severe head trauma due to what appears to be neurogenesis—it’s ability to grow new nerves in the brain. 12. Marijuana seeds produce both male and female plants. However, the medicinal bud only is found on the female plants. 13. You don’t have to ingest marijuana to benefit from its healing abilities. Marijuana buds and leaves can be melted into oils and cocoa butters to make potent topical pain killing ointments that do not get you high. Betty’s (Little Basement) Garden tells the story of one woman’s path to self-discovery about who she really is. What happens when you turn your back on everything that you believed? Follow Betty on her journey from an anti-cannabis staunch Republican to a pro-cannabis free spirit. For more information on the book, please visit the following website: www.TheStoryPlant.com - The book will be released on June 12, 2012. Trix

Study Shows Correlation between Medical Marijuana Laws and Lower Traffic Deaths http://www.jdjournal.com/2012/05/08/study-shows-correlation-between-medical-marijuana-laws-and-lower-traffic-deaths/ Study Shows Correlation between Medical Marijuana Laws and Lower Traffic Deaths According to a study released late in 2011, laws for medical-marijuana reduce traffic deaths. The study is titled ‘Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption.” It was written by D. Mark Anderson and Daniel I. Rees from the Institute for the Study of Labor. One reason for this might be the fact that those living in states where there are medical marijuana laws in place might substitute marijuana for alcohol, which has a deadlier effect when it is combined with driving. Since 1996, the District of Columbia and 15 other states have passed medical marijuana laws. Researchers working on the new study paged through data from the National Highway Traffic Safety Administration prior to and after these laws were passed by the government. Those working on the study found close to a 9 percent decrease in overall traffic deaths. The researchers also took into account the trends in nearby states. The decline in the amount of traffic deaths could be contributed to a drop in traffic deaths related to alcohol use. The researchers also found that in the states that have legalized medical marijuana, people over the age of 18 have increased their consumption outside of prescription uses. The researchers also looked at data from the Centers of Disease Control and from the individual states. That data showed the researchers that the states have also seen a minor decrease in the consumption of alcohol. The researchers claim that when taken together, the data shows that marijuana is now being used to partially replace drinking, not as a supplement to it. Researchers said that those who are high are more likely to be aware of their inebriation, making them less likely to be aggressive and reckless, unlike being drunk. Researchers also suggest that another reason for the drop in traffic deaths could be that people who use marijuana tend to do so in private instead of at a bar or a sporting event like those who consume alcohol.